Sale!

C15orf41 Gene Dyserythropoietic Anemia Congenital Type 1B NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The C15orf41 Gene Dyserythropoietic Anemia Congenital Type 1B NGS Genetic DNA Test is a specialized diagnostic tool that identifies mutations in the C15orf41 gene responsible for congenital dyserythropoietic anemia type 1B (CDA1B). This comprehensive next-generation sequencing test analyzes the complete coding region of the C15orf41 gene to detect pathogenic variants that disrupt normal red blood cell production. Patients with unexplained anemia, abnormal red blood cell morphology, or family history of blood disorders benefit from this precise genetic analysis. The test provides crucial information for accurate diagnosis, enabling targeted treatment strategies and genetic counseling. Results help differentiate CDA1B from other forms of anemia and guide appropriate clinical management. Available for $500 USD, this advanced genetic testing offers valuable insights for hematologists and genetic specialists managing complex blood disorders.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

C15orf41 Gene Dyserythropoietic Anemia Congenital Type 1B NGS Genetic DNA Test

Comprehensive Genetic Analysis for Rare Blood Disorders

The C15orf41 Gene Dyserythropoietic Anemia Congenital Type 1B NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying mutations associated with congenital dyserythropoietic anemia type 1B (CDA1B). This rare inherited blood disorder affects the bone marrow’s ability to produce healthy red blood cells, leading to chronic anemia and potential complications throughout life. Our advanced next-generation sequencing technology provides comprehensive analysis of the C15orf41 gene, offering unparalleled accuracy in detecting pathogenic variants that contribute to this complex hematological condition.

What This Test Measures and Detects

This specialized genetic test utilizes next-generation sequencing (NGS) technology to thoroughly examine the C15orf41 gene for mutations responsible for congenital dyserythropoietic anemia type 1B. The test specifically identifies:

  • Point mutations, insertions, and deletions in the C15orf41 gene coding regions
  • Pathogenic variants affecting erythroid precursor cell development
  • Genetic alterations that disrupt normal erythropoiesis (red blood cell production)
  • Inherited mutations following autosomal recessive patterns
  • Novel variants with potential clinical significance

Who Should Consider This Genetic Test

This comprehensive genetic analysis is recommended for individuals presenting with:

  • Unexplained chronic anemia from childhood or early adulthood
  • Abnormal red blood cell morphology observed in peripheral blood smears
  • Family history of congenital dyserythropoietic anemia or similar blood disorders
  • Ineffective erythropoiesis with elevated serum erythropoietin levels
  • Hematological abnormalities unresponsive to conventional iron therapy
  • Clinical suspicion of inherited bone marrow failure syndromes
  • Patients requiring differential diagnosis between various congenital anemia types

Clinical Benefits of Genetic Testing

Undergoing the C15orf41 gene test provides numerous advantages for patients and healthcare providers:

  • Accurate Diagnosis: Precise identification of CDA1B enables targeted treatment strategies
  • Family Planning: Genetic counseling based on confirmed mutations assists in reproductive decisions
  • Personalized Management: Tailored therapeutic approaches based on specific genetic findings
  • Prognostic Information: Understanding disease progression and potential complications
  • Differential Diagnosis: Clear distinction from other congenital anemia subtypes
  • Research Contribution: Participation in advancing understanding of rare hematological disorders

Understanding Your Test Results

Our comprehensive genetic report provides detailed interpretation of your C15orf41 gene analysis:

  • Positive Result: Identification of pathogenic variants confirms CDA1B diagnosis and enables appropriate clinical management
  • Negative Result: Absence of known pathogenic mutations suggests alternative causes for hematological symptoms
  • Variant of Uncertain Significance: Novel genetic changes requiring further clinical correlation and family studies
  • Carrier Status: Identification of individuals with single mutated copies who may pass the condition to offspring

All results include detailed clinical correlations and recommendations for follow-up care with hematology and genetics specialists.

Test Pricing and Availability

Test Description Price (USD)
C15orf41 Gene Dyserythropoietic Anemia Congenital Type 1B NGS Genetic DNA Test – Discount Price $500
C15orf41 Gene Dyserythropoietic Anemia Congenital Type 1B NGS Genetic DNA Test – Regular Price $700

Nationwide Testing Availability

We provide comprehensive genetic testing services across the United States with convenient locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, high-quality results regardless of your location.

Take Control of Your Genetic Health Today

Don’t let uncertainty about your hematological condition delay proper diagnosis and treatment. Our specialized C15orf41 gene testing provides the clarity needed for effective medical management. Contact our genetic counseling team to discuss your testing options and schedule your appointment.

Call or WhatsApp our genetic specialists today: +1(267) 388-9828

Our experienced team is ready to assist you with pre-test counseling, sample collection coordination, and result interpretation. Take the first step toward understanding your genetic health and receiving personalized care for congenital dyserythropoietic anemia.